Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
Individual responses vary based on baseline A1C, dose level, adherence, and lifestyle factors
Retatrutide's triple-agonist mechanism produced the highest weight loss of any anti-obesity agent in clinical trials (28.7% at 68 weeks in Phase 3 TRIUMPH-4), confirming that the addition of GIP receptor agonism to the GLP-1/glucagon backbone provides substantial incremental benefit
[1] While these mechanisms contribute to improved glycemic control and weight loss, they also create specific hydration challenges that patients and clinicians must address proactively
For patients with moderate renal impairment (eGFR greater than or equal to 30 mL/min/1.73 m2 to less than 45 mL/min/1.73 m2), the dose of JANUVIA is 50 mg once daily
US$ 27.74
US$ 27.02
US$ 22.29
US$ 21.03
US$ 20.20
US$ 29.77
